Loading...
Pancreatic cancer derived 3D organoids as a clinical tool to evaluate the treatment response
Advisor
Date
2023-01-12
Embargo until
Language
Book title
Publisher
Peer Reviewed
Type
Article
Research Area
Jurisdiction
Collections
Other Titles
See at
Abstract
Pancreatic cancer (PC) is the fourth leading cause of cancer death in both men and women. The standard of care for patients with locally advanced PC of chemotherapy, stereotactic radiotherapy (RT), or chemo-radiation-therapy has shown highly variable and limited success rates. However, three-dimensional (3D) Pancreatic tumor organoids (PTOs) have shown promise to study tumor response to drugs, and emerging treatments under in vitro conditions. We investigated the potential for using 3D organoids to evaluate the precise radiation and drug dose responses of in vivo PC tumors.
Data Availibility
Data / Code Location
Table of Contents
Description
The article processing charges (APC) for this open access article were partially funded by the Health Sciences and Human Services Library's Open Access Publishing Fund for Early-Career Researchers.
Citations
Altmetric:
Series/Report No.
Sponsors
Rights/Terms
Attribution-NonCommercial-NoDerivatives 4.0 International